Loading...
STNG is not a good buy right now for an impatient trader. The chart is extended (RSI very high) and price is pressing into a nearby resistance zone (64.48), while the most recent major analyst stance (BofA) is Underperform with a price target ($56) below the current price ($63.8). Despite supportive tanker-rate news and bullish momentum, the near-term risk/reward is unfavorable at this level; the better entry would be on a pullback toward ~62.8 or ideally ~60 support.
Trend/momentum: Bullish. Moving averages are stacked positively (SMA_5 > SMA_20 > SMA_200) and MACD histogram (+0.696) is above zero and expanding, confirming upside momentum.
Overbought/extension: RSI_6 is 75.2 (overbought/extended), implying elevated odds of a near-term pause or pullback rather than a clean breakout.
Levels: Pivot 60.07. Support S1 ~57.35 (deeper S2 ~55.67). Resistance R1 ~62.80 has been surpassed; next resistance R2 ~64.48 is close to the current post-market price (63.82). From a trader’s perspective, buying right under R2 with RSI stretched is a poor immediate entry; a pullback/retest improves odds.
Quant-style pattern read: Similar-pattern stats imply slightly negative drift next day/week (-0.64% / -1.28%) with modestly positive 1-month bias (+1.28%), aligning with “near-term digestion, longer-term trend still constructive.”
Intellectia Proprietary Trading Signals

on 2026-02-12 pre-market could be a catalyst if rates/realizations surprise upward.
increases probability of a pullback rather than immediate upside follow-through.
Latest quarter provided: 2025/Q3. Growth trends (YoY): Revenue $241.36M (-9.94%), Net Income $84.45M (-46.79%), EPS $1.73 (-45.25%). Gross margin 49.99% (-5.34%). Interpretation: Profitability and earnings power are clearly down YoY, consistent with a normalization/softening versus prior peak conditions—this supports the “late-cycle” concern even though spot-rate news is currently favorable.
Recent trend: Ratings/targets have turned more cautious recently. After bullish targets in late 2025 (Evercore Outperform PT $80; BofA Buy PT $73), BofA downgraded STNG to Underperform on 2026-01-09 (PT $53) and then only modestly raised the PT to $56 on 2026-01-20 while keeping Underperform. Wall Street pros: Strong balance-sheet actions and asset monetization; constructive through tanker cycles (Evercore’s thesis). Wall Street cons: View that earnings/rates are near peak, risk of declining rates and rising capacity, and potential geopolitical normalization (BofA’s thesis). With the stock around ~$63.8, the most recent BofA target remains meaningfully below spot price, which is a direct near-term headwind for a new buy.